Focus Stocks
Are the Bears Taking Control over Allergan?
Published on Monday, 05 December 2011 04:18 Written by Danny Miller
New York, December 5th (TradersHuddle.com) - Shares of Allergan Inc. ( NYSE:AGN) ended the trading session lower by $0.61 or -0.72% from its previous close. Allergan's price action formed what is considered to be a bearish engulfing candlestick chart pattern.
Allergan, Inc. ( NYSE:AGN) is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics and medical devices. The company develops products for the ophthalmic, neurological, medical aesthetics, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
Allergan's current stock range is defined by calculated support defined at $78.42 and by the resistance level at $89.25, which should be used by traders planning their trades.
Traders wanting to establish a position in Allergan stock need to pay close attention at the bearish engulfing pattern, since it could mark a trend reversal to current Allergan shares price action. The Bearish engulfing pattern is a leading warning sign, therefore traders should closely monitor price action for indications of a trend reversal. Below an Engulfing Bearish Candle Illustration:

Related Articles
- Allergan Is Dipping Below Support
- Trading Idea: Momentum Building in Allergan
- Allergan Reports First Quarter 2012 Operating Results
- Allergan Is Close to the 50 Day Moving Average
- BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
- Is Allergan Closing in to Resistance?
- Allergan Is Near its 50 Day Moving Average
- Allergan Announces Quarterly Conference Call
- Allergan Announces Positive Top-Line Results from Phase III BOTOX® Overactive Bladder Program
- Close to the 50 Day Moving Average: Allergan
Related Partner Headlines
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) - TheStreet.com
- Ex-Dividend Stocks: Thomson Reuters, Infosys - TheStreet.com
- Allergan Inc. (AGN): Today's Featured Drugs Winner - TheStreet.com
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- Signs Point to MAP Pharma Drug Rejection - TheStreet.com
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- Allergan Stock Hits New 52-Week High (AGN) - TheStreet.com
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) - TheStreet.com
- 9 Ex-Dividend Stocks With Buy Ratings - TheStreet.com
- UPDATE: Morgan Stanley Raises Allergan's PT - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
A Primer on Post-2008 Risk Management - TheStreet.com -
Brightpoint Stock Hits New 52-Week Low (CELL) - TheStreet.com -
Symantec Stock Hits New 52-Week Low (SYMC) - TheStreet.com -
JPMorgan Drops Buyback Plans, Stock Sinks - TheStreet.com -
CEVA Stock Hits New 52-Week Low (CEVA) - TheStreet.com -
First Solar Stock Hits New 52-Week Low (FSLR) - TheStreet.com -
DeVry Stock Hits New 52-Week Low (DV) - TheStreet.com -
Stock Market Story: May 21 - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,452.41 Trade time:10:31AM EDT Value change:▲83.03 (0.67%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,306.69 Trade time:10:31AM EDT Value change:▲11.47 (0.89%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,806.89 Trade time:10:31AM EDT Value change:▲28.10 (1.01%)In The Wires
-
Lockheed Martin's Aegis Computer Program Development Approved by U.S. Navy for Australian Warfare Destroyer -
PartyLite Worldwide Selects TradeStone Software's Merchandise Lifecycle Management Suite for Product Development Needs -
Photo Release -- Charley's Grilled Subs 'Spices it Up' With Chipotle Chicken Sandwich -
Audi Customers to Get 4-Year SiriusXM Traffic Subscription Beginning with Select Model Year 2013 Vehicles -
S&P Capital IQ Introduces Customer Relationship Management (CRM) Data Suite Offering -
Westinghouse, Burns & McDonnell and Electric Boat Collaborate in Applying for DOE SMR Funding Opportunity -
Pershing Announces Groundbreaking Collateral Management Technology for Fund Managers -
Ticketmaster to Provide Primary and Resale Ticketing Solution for Barclays Center









